Cargando…

FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation

Recently, we found a strict bone association between Fibroblast growth factor 23 (FGF23) and Fetuin-A, both involved in cardiovascular and mineral bone disorders. In this study, an uninvestigated bone marrow positivity for both was found. Though the role of exogenous FGF23 on mesenchymal cells (MSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattinzoli, Deborah, Ikehata, Masami, Tsugawa, Koji, Alfieri, Carlo M., Barilani, Mario, Lazzari, Lorenza, Andreetta, Paola, Elli, Francesca M., Mantovani, Giovanna, Messa, Piergiorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412477/ https://www.ncbi.nlm.nih.gov/pubmed/30791553 http://dx.doi.org/10.3390/ijms20040915

Ejemplares similares

FGF23 and Fetuin-A Interaction in the Liver and in the Circulation
por: Mattinzoli, Deborah, et al.
Publicado: (2018)

Fibroblast growth factor 23 level modulates the hepatocyte’s alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB
por: Mattinzoli, Deborah, et al.
Publicado: (2022)

MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD
por: Mattinzoli, Deborah, et al.
Publicado: (2022)

MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

Carbon dots conjugated to SN38 for improved colorectal anticancer therapy
por: Mattinzoli, Deborah, et al.
Publicado: (2022)

Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial
por: Caldiroli, Lara, et al.
Publicado: (2022)

Urinary mRNA Expression of Glomerular Podocyte Markers in Glomerular Disease and Renal Transplant
por: Armelloni, Silvia, et al.
Publicado: (2021)

Is there a role in acute kidney injury for FGF23 and Klotho?
por: Mattinzoli, Deborah, et al.
Publicado: (2023)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes
por: Alfieri, Carlo Maria, et al.
Publicado: (2021)

Bone and Mineral Disorder in Renal Transplant Patients: Overview of Pathology, Clinical, and Therapeutic Aspects
por: Molinari, Paolo, et al.
Publicado: (2022)

Novel Pathogenetic Variants in PTHLH and TRPS1 Genes Causing Syndromic Brachydactyly
por: Elli, Francesca Marta, et al.
Publicado: (2022)

Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design
por: Rivera-Ordaz, Araceli, et al.
Publicado: (2021)

Clinical Impact of Hypercalcemia in Kidney Transplant
por: Messa, Piergiorgio, et al.
Publicado: (2011)

Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study
por: Alfieri, Carlo, et al.
Publicado: (2021)

COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis
por: Fabrizi, Fabrizio, et al.
Publicado: (2020)

Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations
por: Trudu, Matteo, et al.
Publicado: (2017)

NG2 as an Identity and Quality Marker of Mesenchymal Stem Cell Extracellular Vesicles
por: Barilani, Mario, et al.
Publicado: (2019)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course
por: Kukla, Michał, et al.
Publicado: (2021)

Fetuin-A and risk of diabetes-related vascular complications: a prospective study
por: Birukov, Anna, et al.
Publicado: (2022)

Nutritional Vitamin D in Renal Transplant Patients: Speculations and Reality
por: Messa, Piergiorgio, et al.
Publicado: (2017)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Fetuin-A, fibroblast growth factor 23 and inflammation in critically ill patients with sepsis
por: Fajol, Abul
Publicado: (2021)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women
por: Ramanjaneya, Manjunath, et al.
Publicado: (2020)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Nanobacteria Are Mineralo Fetuin Complexes
por: Raoult, Didier, et al.
Publicado: (2008)

Fetuin-A levels in hyperthyroidism
por: Pamuk, Barış Onder, et al.
Publicado: (2013)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_01l1o680mnb2o3d7vudmafs652